Mechanisms of inhibition by cyclosporin A on pulmonary leukocyte accumulation.
Sandoz Pharma Ltd, Basel, Switzerland.
I
I
Chapman
L
L
Mazzoni
D000818:Animals; D001249:Asthma / Q000473:pathology*; D016572:Cyclosporine / Q000494:pharmacology*; D016207:Cytokines / Q000096:biosynthesis; D004730:Endothelium, Vascular / Q000187:drug effects / Q000473:pathology; D004848:Epithelium / Q000187:drug effects / Q000473:pathology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects* / Q000276:immunology; D008168:Lung / Q000187:drug effects* / Q000473:pathology*; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects / Q000276:immunology
D016207:Cytokines; D016572:Cyclosporine